Laura Ray
About Laura Ray
Laura Ray is the Associate Director, Pharmacovigilance Scientist at Bristol-Myers Squibb in New Jersey, with extensive experience in drug safety and regulatory affairs.
Current Title at Bristol-Myers Squibb
Laura Ray is currently the Associate Director, Pharmacovigilance Scientist at Bristol-Myers Squibb. She works in New Jersey, United States, and is responsible for providing scientific and technical support for Safety Surveillance Team (SST) and Medical Surveillance Team (MST) meetings. Her role involves compiling and disseminating aggregate data for safety signal detection, and interacting with various departments to address specific drug safety issues.
Previous Roles at Bristol-Myers Squibb
Before becoming the Associate Director, Pharmacovigilance Scientist, Laura Ray served in various capacities at Bristol-Myers Squibb. She was a Senior Safety Scientist from 2003 to 2013 and a Regulatory Safety Associate focusing on Adverse Event Processing from 2001 to 2003. Her extensive experience at the company spans multiple facets of drug safety and regulatory compliance.
Early Career Experience in Pharmaceutical Industry
Laura Ray has a wealth of experience in the pharmaceutical industry, beginning as a Drug Experienced Specialist at Johnson & Johnson from 1999 to 2001. Additionally, she served as a Nursing Supervisor and Nurse Manager at Horsham Clinic between 1995 and 1999, and as a Nurse Coordinator at Eastern State School and Hospital from 1988 to 1995. Her background provides a solid foundation in clinical and safety practices.
Educational Background in Nursing
Laura Ray studied Nursing at Drexel University, where she completed her studies from 1985 to 1988. Her formal education in nursing has served as a critical foundation for her extensive career in pharmacovigilance and safety science.
Specialized Expertise in Pharmacovigilance
Laura Ray has over 10 years of experience in direct authoring and quality review of Global Regulatory documents. She specializes in therapeutic areas including AIDS/HIV, Cardiovascular, Central Nervous System, Metabolic, Oncology, and Psychiatric diseases. Her expertise extends to Consumer Products, Medical Devices, and Medical Imaging. Additionally, she performs database reconciliation for safety data analysis and reviews safety data from various clinical reports, providing valuable insights for drug safety evaluations.